This is a partitioner-only product. Purchasing this product/supplement requires either:

  • A complimentary phone consultation by us to discuss your needs and determine whether this product is suitable for you; or

  • A script or referral documentation from a qualified health professional.

  • Skip to product information
    1 of 3


    Bio Absorb PEA Advanced- Metagenics

    Bio Absorb PEA Advanced- Metagenics

    Tax included. Shipping calculated at checkout.

    ➤ Don't have a password yet?

    Bio Absorb PEA Advanced in New Zealand

    High Strength, Enhanced Absorption PEA For Mild Nerve Pain Combined With Saffron.

    • For the relief of mild nerve pain, neuralgia, and compression neuropathy.
    • Breaks the pain cycle by targeting drivers of pain amplification, is analgesic and enhances endocannabinoid activity.
    • A highly bioavailable form of PEA using the Levagen+™ (LipiSperse®) delivery system, with affron® and vitamin B1.


    Clinical Benefits:

    Bio Absorb PEA Advanced relieves neuropathic pain, such as sciatica, neuropathies and neuralgia.


    Clinical Research of PEA


    Palmitoylethanolamide (PEA) is neuroprotective, anti-inflammatory, and analgesic4 due to its endocannabinoid (eCB) action. PEA affects eCB  signalling through peroxisome proliferator-activated receptor alpha (PPAR-α)  activation6and is capable of exerting antiallodynic and anti-hyperalgesia  effects by downmodulating both microglial and mast cell activity which has led to its use for neuropathic pain. Both TRPA1 (transient receptor potential ankyrin 1) and TRPV1 (transient receptor potential vanilloid type 1) are co-expressed in sensory neurons and are implicated in neuropathic pain, hyperalgesia and neural amplification.8Animal studies have shown that a main phytoconstitutent of saffron, safranal, desensitises TRPA1 and PEA desensitises TRPV1. In addition, vitamin B1 deficiency results in neuropathic pain and vitamin B1 was found to significantly reduce dorsal root ganglia neuron excitability in vitro, a provocating factor in central sensitisation of pain.

    1 in 5 of chronic pain sufferers have neuropathic pain. Patients presenting inadequate response to drug treatment can partly be explained by the hyperalgesia that is associated with long-term opioid use. PEA and saffron have been found to be safe to use alongside common pain medication in certain individuals*.


    PEA, Saffron and Vitamin B1 in the Pain Cycle


    Levagen+™ uses LipiSperse® technology for enhanced absorption and is 70% better absorbed (Figure 2) leading to greater plasma levels over time compared to a standard PEA. 600 mg/d of Levagen+™ PEA is likely to equate to consuming 1,000 mg of a standard micronized PEA. Practitioners can expect Levagen+™ to produce greater efficacy and to last longer in the body.


     Levagen+™ PEA vs Standard PEA.


    Levagen+™ is owned by Gencor Pacific Limited. affron® is a registered trademark of Pharmactive Biotech Products, S.L.
    *Always check patient medications for interactions and safety.



    Adults: Take 1 capsule twice daily.



    This medicine is not to be used for more than 21 consecutive days, and may interact with other prescription analgesic medicines. Please consult your healthcare practitioner before use. Suitable for individuals 18 years and over. Vitamins supplements should not replace a balanced diet.



    Store below 30°C.

    Pack: 42 Capsules
    View full details